🇺🇸 FDA
Patent

US 9073985

Methods and products for treating proliferative diseases

granted A61KA61K2039/505A61K31/4409

Quick answer

US patent 9073985 (Methods and products for treating proliferative diseases) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/505, A61K31/4409, A61K31/4706, A61K31/7004